Tag: Biopharmaceuticals

DBV Technologies: CEO to Present at Guggenheim Biotech Summit 2026

February 10, 2026

DBV Technologies: CEO to Present at Guggenheim Biotech Summit 2026

Biocon Biologics: Fully Owned Subsidiary – $5.5 Billion Deal

December 6, 2025

Biocon Biologics: Fully Owned Subsidiary – $5.5 Billion Deal

Novo Nordisk Sales Outlook Downgraded: Pfizer Bid for Metsera Intensifies

November 5, 2025

Novo Nordisk Sales Outlook Downgraded: Pfizer Bid for Metsera Intensifies

AstraZeneca Breast Cancer Drug Breakthroughs

October 20, 2025

AstraZeneca Breast Cancer Drug Breakthroughs

Web Analytics Made Easy - Statcounter